Sun Pharma Advanced Research Co P/E Ratio
Current P/E Ratio
4.76
Low Valuation
Very Low - Potentially undervalued or facing challenges
Sun Pharma Advanced Research Co (SPARC) P/E ratio is 4.76 (Low), EPS (TTM) ₹47.86, current price ₹216.23 on NSE — Very Low - Potentially undervalued or facing challenges. See Sun Pharma Advanced Research C P/B ratio trends to compare market price against book value per share.
Current Valuation Metrics
P/E Ratio
4.76
Current Price
₹216.23
EPS (TTM)
₹47.86
Exchange
NSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
55.9
Sector Median
31.44
Sector Rank
#4 of 194
Sector Percentile
2.1%
Earnings Breakdown (TTM)
TTM EPS
₹48.49
Mar 2026
₹54.27
Sept 2025
₹-2.34
SPARC P/E Ratio — Valuation Signal & Historical Context
Sun Pharma Advanced Research Co P/E 4.76 — signal: Undervalued. Read SPARC dividend payout details for the complete payout history and dividend yield track record.
- Stock appears undervalued with PE of 4.76, suggesting potential buying opportunity
- Trading at discount to sector average PE of 55.9
SPARC vs Healthcare Peers — P/E Ratio Comparison
Sun Pharma Advanced Research Co P/E 4.76 vs Healthcare average 55.9, median 31.44 — range 2.86–916.67.
Sector Average
55.9
Sector Median
31.44
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.76 | ₹30 | Low |
| Shelter Pharma | SHELTER | 5.23 | ₹47 | Low |
| Dipna Pharmachem | DPL | 5.39 | ₹14 | Low |
| JFL Life Sciences | JFLLIFE | 5.41 | ₹68 | Low |
| Amwill Health Care | AMWILL | 7.26 | ₹83 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹84 | Low |
| Galaxy Medicare | GML | 7.8 | ₹27 | Low |
| Royal Sense | ROYAL | 8.0 | ₹57 | Low |